Answers are grounded in this paper and cite their sources.
Most head and neck cancers can be treated with curative intent. Up to 50% of patients can present with recurrent or metastatic disease. For locoregional recurrence, salvage surgery is the preferred treatment option. When applicable, reirradiation can be useful after surgery or as a definitive treatment. For patients with incurable disease, checkpoint inhibitors serve as the backbone of treatment regimens. Despite recent advances, immunotherapy will fail patients most of the time. Novel approaches are being utilized to enhance the responses with immunotherapy with the hopes of providing increased durability.
No takes yet. Share an insight, caveat, or question.
Paydary et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: